Comparison of Select analytes in Exhaled aerosol from E-Cigarettes with Exhaled Smoke from a Conventional Cigarette and Exhaled Breaths
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Long (2014)
Effects of Electronic Cigarette Liquid Nicotine Concentration on Plasma Nicotine and Puff Topography in Tobacco Cigarette Smokers: a Preliminary Report
Individual Clinical
User Topography
Lopez (2016)
a systematic review and meta-analysis of e-cigarette use among cancer survivors.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Lopez-Olivo (2023)
Comparison of Urinary Biomarkers of Exposure in humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Lorkiewicz (2019)
Electronic Cigarette Solvents, JUUL E-Liquids, and Biomarkers of Exposure: In Vivo Evidence for acrolein and Glycidol in E-Cig-Derived aerosols.
Nonclinical
Chemical
Analysis
Lorkiewicz (2022)
addicted to smoking or addicted to nicotine? a focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non-smokers and dual users of cigarettes and e-cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loud (2022)
Electronic nicotine delivery systems (ENDS) dependence among Texas Young adults, 2014-2019: Increasing trajectory after the 2017 surge in vape pod popularity.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loukas (2022)
Electronic nicotine delivery systems use predicts transitions in cigarette smoking among young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loukas (2022)
Rising vape pod popularity disrupted declining use of electronic nicotine delivery systems among young adults in Texas, USa from 2014 to 2019.
Population Clinical
Consumer Use
Youth Use & Appeal
Loukas (2022)
Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months.
Population Clinical
Population Health Impact
Lucchiari (2020)